Renal Tumour Imaging Using MRI
NCT07173140 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-09-15
Summary
This study investigates whether new types of MRI scans can tell the difference between different kidney tumours before surgery. Currently, imaging scans can detect kidney tumours and their size, but they aren't effective at determining the tumour type or its aggressiveness. Biopsies are an option, but they are invasive and may miss important cancerous cells. The aim is to use imaging to determine which tumours are aggressive so they can be treated early while avoiding unnecessary treatment of benign tumours.
Patients with small renal tumours (≤ 7 cm) who meet the other inclusion and exclusion criteria will be asked to have an additional MRI scan at University College London Hospital prior to surgery.
The imaging findings will be compared to the histology result from the removed tumour. In 10 patients the histology will be targeted to a specific location in the tumour based on the imaging. 10 patients will undergo a repeat MRI \<14 d apart to test whether the MRI scans can give the same answer twice (the test repeatability).
The study is expected to run for 24 months and is funded by NIHR.
The chief investigator for the study is Dr Richard Hesketh ([email protected]).
Conditions
- Renal Cancer
- MRI
- Small Renal Mass
- Kidney Cancers
Interventions
- DIAGNOSTIC_TEST
-
MRI
Participants undergo an additional MRI scan using novel MRI sequences
Sponsors & Collaborators
-
Royal Free Hospital NHS Foundation Trust
collaborator OTHER -
University College London Hospitals
collaborator OTHER -
University College, London
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-20
- Primary Completion
- 2025-06-19
- Completion
- 2025-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
PET/MR for Characterization of Renal Masses (RMs)
NCT06076538 ·Status: RECRUITING
-
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089 ·Status: RECRUITING ·Phase: PHASE2
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
MRI in Diagnosing Solid Tumors of the Eye and Orbit
NCT01653080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
NCT04258462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
NCT07181954 ·Status: COMPLETED
-
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
NCT02287701 ·Status: COMPLETED ·Phase: NA
-
Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging
NCT00842790 ·Status: COMPLETED
-
Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617
NCT05170555 ·Status: UNKNOWN ·Phase: NA
-
Comparison of the Diagnostic Accuracy of 3D Volume Acquisition MRI With CT in Staging Colonic Cancer
NCT01187641 ·Status: COMPLETED
-
RGD-PET-CT in Cancer Angiogenesis
NCT01492192 ·Status: TERMINATED ·Phase: PHASE2
-
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma
NCT06428708 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
NCT06148220 ·Status: RECRUITING ·Phase: NA
-
68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
NCT05879510 ·Status: UNKNOWN ·Phase: PHASE2
-
7T MRI Scan for the Early Detection of Melanoma Brain Metastases
NCT04941430 ·Status: TERMINATED ·Phase: NA
-
Hepatic and Renal Thermography Using Magnetic Resonance Imaging
NCT01197820 ·Status: TERMINATED ·Phase: NA
-
68Ga-PSMA PET in the Renal Cell Carcinoma
NCT04987086 ·Status: RECRUITING ·Phase: NA
-
PET/CT-Assessment of Liver Tumor Ablation
NCT02018107 ·Status: COMPLETED ·Phase: NA
-
68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
NCT07101900 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
GlucoCEST MRI in Oncology
NCT03212157 ·Status: COMPLETED ·Phase: NA
-
Advanced Diffusion Imaging in Renal Cancer Patients
NCT06116253 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226 ·Status: RECRUITING ·Phase: NA
-
Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques
NCT02747173 ·Status: TERMINATED
-
Clinical Study of 18F -FAPI-RGD in Renal Tumor
NCT05976607 ·Status: COMPLETED
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA